An 83‐year‐old female had asymptomatic SARS‐CoV‐2 infection while taking ruxolitinib. She remained RT‐PCR positive for viral RNA for >120 days, and Pegylated interferon for 4 weeks led to viral RNA clearance. The observations support combination therapy of ruxolitinib + interferon for COVID‐19.
An 83 year old female had asymptomatic SARS-CoV-2 infection while taking
ruxolitinib. She remained RT-PCR positive for viral RNA for
>120 days, Pegylated interferon for 4 weeks led to viral
RNA clearance. The observations support combination therapy of
ruxolitinib + interferon for COVID-19.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.